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AbstrACt
Introduction Cataract is the leading cause of blindness 
globally and a major cause of vision impairment. Cataract 
surgery is an efficacious intervention that usually 
restores vision. Although it is one of the most commonly 
conducted surgical interventions worldwide, good quality 
services (from being detected with operable cataract to 
undergoing surgery and receiving postoperative care) are 
not universally accessible. Poor quality understandably 
reduces the willingness of people with operable cataract 
to undergo surgery. Therefore, it is critical to improve 
the quality of care to subsequently reduce vision loss 
from cataract. This scoping review aims to summarise 
the nature and extent of the published literature on 
interventions to improve the quality of services for primary 
age- related cataract globally.
Methods and analysis We will search MEDLINE, 
Embase and Global Health for peer- reviewed manuscripts 
published since 1990, with no language, geographic 
or study design restrictions. To define quality, we have 
used the elements adopted by the WHO—effectiveness, 
safety, people- centredness, timeliness, equity, integration 
and efficiency—to which we have added the element of 
planetary health. We will exclude studies focused on the 
technical aspects of the surgical procedure and studies 
that only involve children (<18 years). Two reviewers will 
screen all titles/abstracts independently, followed by a 
full- text review of potentially relevant articles. For included 
articles, data regarding publication characteristics, study 
details and quality- related outcomes will be extracted by 
two reviewers independently. Results will be synthesised 
narratively and presented visually using a spider chart.
Ethics and dissemination Ethical approval was not 
sought, as our review will only include published and 
publicly accessible information. We will publish our 
findings in an open- access peer- reviewed journal and 
develop an accessible summary of the results for website 
posting. A summary of the results will be included in the 
ongoing Lancet Global Health Commission on Global Eye 
Health.
registration details Open Science Framework (https:// 
osf. io/ 8gktz).
IntroduCtIon
Cataract is the leading cause of blindness glob-
ally and a major cause of moderate and severe 
vision impairment—an estimated 65 million 
people had vision loss from cataract in 2015.1 
Vision loss from cataract is unequally distrib-
uted throughout the world. For example, in 
2015, among adults aged 50 years and above, 
the age- standardised prevalence of cataract 
blindness ranged from 0.08% (80%, uncer-
tainty interval (UI) 0.03%–0.19%) in high- 
income countries of the Asia Pacific region 
to 2.35% (80%, UI 0.72%–5.04%) in West 
sub- Saharan Africa—almost a 30- fold differ-
ence.1 Inequality (ie, measurable differ-
ences between population subgroups) is also 
evident within countries, with a higher prev-
alence of cataract blindness among socially 
disadvantaged groups such as women, rural 
dwellers and those who are not literate.2
Cataract surgery is an efficacious inter-
vention that can restore vision3–5 and alle-
viate poverty.6 It is one of the most common 
surgical interventions in many high- income 
strengths and limitations of this study
 ► A strength of this review is the use of a broader 
concept of quality beyond the common measure of 
postoperative visual acuity—we included the seven 
elements of quality outlined in WHO’s framework for 
healthcare quality, as well as the element of plane-
tary health.
 ► Another strength is that we have broadened the 
scope of cataract services beyond the surgical in-
tervention itself to identify interventions to improve 
quality along the care pathways, from detection and 
referral to uptake of services through to postopera-
tive care.
 ► This study will not include studies that assess spe-
cific surgical techniques and/or specific products 
and medications as this extensive literature is com-
monly synthesised in Cochrane and other reviews.
 ► This review will summarise the nature and extent of 
the literature on interventions to improve the quality 
of cataract services but will not assess the quality or 
risk of bias of the studies themselves.
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Figure 1 Elements of healthcare quality considered in this 
review (modified figure 3.2 from World Health Organization24 
by adding planetary health).
countries and some middle- income countries.7 However, 
good quality services are not universally accessible, partic-
ularly in low/middle- income countries (LMICs).8 9 Poor 
quality understandably reduces the willingness of people 
with operable cataract to undergo surgery.10 Therefore, it 
is critical to improve the quality of care to subsequently 
reduce vision loss from cataract.
Quality of cataract services is most commonly measured 
using postoperative visual acuity. Measuring and moni-
toring outcomes is crucial in order to improve them11 and 
tools are available to enable monitoring of postoperative 
visual acuity.12
Beyond using postoperative visual acuity to assess effec-
tiveness, the quality of cataract services includes many 
clinical and non- clinical dimensions.13 For example:
 ► Timeliness: cataract commonly occurs bilaterally. 
In many settings, the current recommendation is to 
operate on one eye at a time and allow enough time 
for the operated eye to heal before operating on the 
second eye. However, delay in surgery for the second 
eye has been linked to increased risk of falls and road 
traffic accidents.14
 ► People- centredness: it may be common for patients to 
have to visit hospitals several times before the surgery 
for different preoperative assessments, even though 
some of these could be done in one visit. Reducing 
the number of hospital visits to get surgery would 
improve quality from the patient perspective.
 ► Equity: there is no physiological reason why 
outcomes should be poorer in women compared 
with men, but women tend to have lower access and 
poorer postoperative vision outcomes compared 
with men.2 15 A further example of inequity is seen in 
the difference in effective cataract surgical coverage 
among indigenous (51.6%, 95% CI: 42.4–60.7) 
and non- indigenous Australians (88.5%, 95% CI: 
85.2–91.2).16
 ► Efficiency (productivity): there is a link between the 
quantity of surgery a surgeon performs and the quality 
of that surgery.17 It has also been demonstrated that 
apparently cheaper service delivery options, such as 
outreach camps, can be less cost- effective compared 
with surgery delivered in static clinics due to worse 
outcomes.18
The aim of this review is to summarise the nature 
and extent of the published literature on interventions 
to improve the quality of cataract services globally. 
We chose to undertake a scoping review rather than 
an alternative evidence synthesis approach because 
we wished to identify and map the available evidence, 
which we anticipate will be heterogeneous.19 20 We will 
take a broad perspective on quality outcomes and rele-
vant interventions of interest, but will exclude studies 
focused exclusively on the technical aspects of surgical 
techniques. For example, we will not include studies 
reporting the effectiveness of phacoemulsification or 
manual small incision surgery, as these are summarised 
in other reviews.3–5 21
definitions and framework development
Cataract services include the range of activities on the 
pathway from detecting people with operable cataract to 
these people undergoing surgery and receiving postoper-
ative care. As such, cataract services are both community 
and facility- based22 and—regardless of the setting—
should involve a broad range of healthcare providers 
from the community level (eg, village health workers 
as case finders) through primary (eg, optometrist) and 
secondary services (ie, surgical team). In addition, consid-
eration of all of the health system building blocks is rele-
vant to strengthen cataract services.
Quality of care is one of the objectives embodied by 
the concept of Universal Health Coverage, together with 
equity in access and financial protection.23 Our review will 
be guided by the definition of the quality of care recently 
outlined by the WHO:
Quality of care is ‘the degree to which health services 
for individuals and populations increase the likeli-
hood of desired health outcomes and are consistent 
with current professional knowledge’.24
WHO has adopted the framework of quality outlined by 
the Institute of Medicine.25 This framework measures the 
quality of healthcare across seven elements, namely, effec-
tiveness, safety, people- centredness, timeliness, equity, 
integration and efficiency.
We have made one addition to the quality elements in 
WHO’s framework—we believe that planetary health is an 
essential element of quality cataract surgery, so will also 
scope the literature on this. Planetary health is focused 
on sustainability, including the ability of the society to 
make choices while balancing the needs of future gener-
ations.26 This modified framework is shown in figure 1.
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To help guide the scope of our review, we mapped 
examples of outcome measures and interventions for 
cataract services against each of the eight elements of 
healthcare quality (table 1). These outcomes and inter-
ventions were drawn from the literature,27 28 as well as the 
knowledge and experience of the authorship group. For 
people- centredness, we drew on the outline of Integrated 
Person- Centred Health Services provided by WHO and 
adopted in the recent World Report on Vision, whereby 
services aim to provide coordinated care that addresses 
the full spectrum of eye conditions according to an indi-
vidual’s needs and recognises people as participants and 
beneficiaries of this care.29 30
When mapping interventions, we categorised them 
using the WHO health systems ‘building blocks’, that is, 
we mapped them to the most relevant of service delivery; 
health workforce/human resources (HR), health infor-
mation system (HIS); access to essential consumables/
non- consumables; financing; and leadership/gover-
nance. Recognising that this framework does not include 
community engagement and empowerment, we added 
community as an additional category against which inter-
ventions could be mapped.31
MEthods And AnAlysIs
objectives/scoping review questions
We aim to answer the following three questions:
1. What interventions to improve the quality of cata-
ract services have been described in the published 
literature?
2. Which element(s) of quality did the interventions ad-
dress?
3. Where was the evidence generated (high- income vs 
middle- income vs low- income settings)?
Protocol and registration
This protocol for this scoping review is reported according 
to the relevant sections of the Preferred Reporting Items 
for Systematic Reviews and Meta- Analyses Extension for 
Scoping Reviews (PRISMA- ScR) guideline (online supple-
mentary annex 1).32
Eligibility criteria
This scoping review will include primary research studies 
of any design and systematic reviews from any country that 
report a quality- relevant outcome for primary age- related 
cataract following an intervention related to the quality 
of cataract services. We will only include studies where 
intervention is compared against any alternatives (eg, 
intervention vs no intervention/current practice vs new 
intervention/before vs after implementation). Examples 
of relevant interventions are provided in table 1, mapped 
against the eight quality elements of interest. Systematic 
reviews will be included only if meta- analysis is conducted 
for a quality- relevant outcome. If we identify systematic 
reviews that report narrative synthesis of quality- relevant 
outcomes without meta- analysis, then we will review the 
list of included studies and include in our scoping review 
any that meets our eligibility criteria.
We will exclude studies assessing specific surgical tech-
niques (eg, phacoemulsification vs manual small incision 
surgery, site of anaesthesia and size of incision) and/
or specific products and medications used during and 
around the time of surgery (eg, monofocal vs multifocal 
intraocular lens; drug A vs drug B) as these are typically 
addressed in other systematic reviews.3 4 21 Studies focused 
exclusively on cataract services for children (aged under 
18 years) will be excluded, as these services differ substan-
tially from those for age- related cataract. We will also 
exclude studies reporting interventions to prevent cata-
ract formation or progression. We will exclude studies 
published prior to 1990, as during the last 30 years, there 
have been a large number of major developments in cata-
ract services that would be expected to have changed the 
‘landscape’ substantially. Service delivery models prior to 
this time are quite different from those currently used. 
There will be no language limitations. Only studies where 
the full text is available will be included.
search
We will search MEDLINE, Embase and Global Health 
databases using search strategies developed by a Cochrane 
Eyes and Vision Information Specialist (IG). The search 
strategy for MEDLINE is included in the online supple-
mentary annex 2. We will examine reference lists of all 
included articles to identify further potentially relevant 
reports of studies. Field experts will be provided a list of 
the included studies and requested to identify further 
potentially relevant studies for consideration in the 
review.
selection of sources of evidence
Covidence systematic review software will be used for 
screening (Veritas Health Innovation, Melbourne, 
Australia. Available at: www. covidence. org). Each title and 
abstract will be screened independently by two reviewers 
(MY, JR, HB, AA, JB, JF, SG and WHD) to exclude publi-
cations that clearly do not meet the inclusion criteria. 
Subsequently, the full- text article will be retrieved for 
review if the citation seems potentially relevant and two 
reviewers will independently assess each article against 
the inclusion and exclusion criteria. Any discrepancies 
between the reviewers will be resolved by discussion and 
a third reviewer will be consulted if necessary. A PRISMA 
flow diagram will be completed to summarise the study 
selection process.
data charting process
A custom form will be developed in Excel for data 
charting. The form will be piloted on three studies and 
required amendments agreed by consensus. We antici-
pate a broad scope of included studies, so data charting 
will be an iterative process throughout the review and the 
data charting form will be amended as required. Each 
included study will be charted independently by two 
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reviewers. Any discrepancies will be resolved by discus-
sion and a third reviewer will be consulted if necessary. 
We plan to contact study authors in the case of unclear 
information and will make up to three attempts by email.
data items
The following data items will be collected during the data 
charting process:
1. Publication characteristics: title, year of publication, 
study design, country of origin and study setting.
2. Characteristics of intervention/study:
a. Context (eg, geographic area, target population 
and distribution, type of interventions (categorised 
by health system building block), target health prac-
titioner and duration/frequency).
b. Quality element(s) addressed by the intervention 
(as outlined in table 1).
3. Outcome(s) of the intervention/study and whether it 
was reported to be effective (ie, had an effect vs had no 
effect) (examples of outcomes are outlined in table 1).
synthesis of results
We recognise that the indication for surgery can vary 
across different settings due to the prevalence of vision 
loss from cataract, the capacity of services and the quality 
and safety standards in each setting. Accordingly, we 
will synthesise results by World Bank country income 
level (high/upper- middle/lower- middle/low)33 and (if 
possible) by Global Burden of Disease super- region (high 
income/Latin America and Caribbean/sub- Saharan 
Africa/North Africa and Middle East/Southeast Asia, East 
Asia and Oceania/South Asia/Central Europe, Eastern 
Europe and Central Asia).34
We will summarise findings narratively and using 
descriptive statistical methods as appropriate. We will 
map each intervention to the relevant quality element. 
We will visualise the findings using spider charts to show 
the extent of the evidence across each quality element 
and will plot evidence in high- income countries sepa-
rately to LMICs. For each intervention, we will quantify 
the number of studies that were reported by the authors 
to be effective (vs having no effect).
Patient and public involvement statement
This protocol was developed with input from the Commis-
sioners of the Lancet Global Health Commission on Global 
Eye Health,35 which includes people with lived experi-
ence of vision impairment (and cataract surgery), policy- 
makers, academics, clinicians, government eye health 
programme leaders and advocacy specialists.
EthICs And dIssEMInAtIon
Ethical approval was not sought, as our review will only 
include published and publicly accessible information.
We will publish our findings in an open- access, peer- 
reviewed journal and develop an accessible summary of 
the results for website posting and stakeholder meetings. 
A summary of the results will also be included in the 
ongoing Lancet Global Health Commission on Global Eye 
Health.35
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